CL
Climb Bio, Inc. (CLYM)
NASDAQ·Healthcare·Biotechnology
$11.33
+3.71%
Mkt Cap $719.35M
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (8 analysts)
$20.00
Range $17.00 – $25.00
Implied Upside
+76.5%
Consensus $20.00 vs current $11.33
NASDAQ·Healthcare·Biotechnology
$11.33
+3.71%
Mkt Cap $719.35M
Buy
11
Hold
0
Sell
0
Price Target (8 analysts)
$20.00
Range $17.00 – $25.00
+76.5%
Consensus $20.00 vs current $11.33